Ovarian hyperstimulation syndrome prevention strategies: Cryopreservation of all embryos

Seminars in Reproductive Medicine

Volumn 28, Issue 6, 2010, Pages 513-518

  D'Angelo, Arianna ^a,b  

^a IVF Wales ^*  (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

cryopreservation; embryo freezing; OHSS; ovarian hyperstimulation syndrome; prevention

Indexed keywords

ALBUMIN; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; MUELLERIAN INHIBITING FACTOR;

BLASTOCYST; CELL CULTURE; CLINICAL TRIAL; CRYOPRESERVATION; EMBRYO TRANSFER; EVIDENCE BASED MEDICINE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY THERAPY; INTRACYTOPLASMIC SPERM INJECTION; OVARY HYPERSTIMULATION; PATIENT MONITORING; REVIEW;

CELL COUNT; CRYOPRESERVATION; EMBRYO, MAMMALIAN; FEMALE; HUMANS; INFERTILITY, FEMALE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 78649233245     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0030-1265679     Document Type: Review

References (33)

1. Forman R G., Frydman R, Egan D, Ross C, Barlow D H. Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention. Fertil Steril 1990 53 (3) 502-509
2. Navot D, Bergh P A., Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 1992 58 (2) 249-261
3. Rabau E, David A, Serr D M., Mashiach S, Lunenfeld B. Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment. Am J Obstet Gynecol 1967 98 (1) 92-98
4. Schenker J G., Weinstein D. Ovarian hyperstimulation syndrome: a current survey. Fertil Steril 1978 30 (3) 255-268
5. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 1989 44 (6) 430-440
6. Lyons C A., Wheeler C A., Frishman G N., Hackett R J., Seifer D B., Haning R V. Jr. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors. Hum Reprod 1994 9 (5) 792-799
7. Sher G, Salem R, Feinman M, Dodge S, Zouves C, Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol 1993 81 (6) 1009-1011
8. Egbase P E., Sharhan M A., Grudzinskas J G. Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. Hum Reprod 1999 14 (6) 1421-1425
9. Araujo E Jr, Bernardini L, Frederick J L., Asch R H., Balmaceda J P. Prospective randomized comparison of human chorionic gonadotropin versus intramuscular progesterone for luteal-phase support in assisted reproduction. J Assist Reprod Genet 1994 11 (2) 74-78
10. Gonen Y, Balakier H, Powell W, Casper R F. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 1990 71 (4) 918-922
11. Kinget K, Nijs M, Cox A M. et al. A novel approach for patients at risk for ovarian hyperstimulation syndrome: elective transfer of a single zona-free blastocyst on day 5. Reprod Biomed Online 2002 4 (1) 51-55
12. Ata B, Yakin K, Alatas C, Urman B. Dual renin-angiotensin blockage and total embryo cryopreservation is not a risk-free strategy in patients at high risk for ovarian hyperstimulation syndrome. Fertil Steril 2008 90 (3) 531-536
13. Amso N N., Ahuja K K., Morris N, Shaw R W. The management of predicted ovarian hyperstimulation involving gonadotropin-releasing hormone analog with elective cryopreservation of all pre-embryos. Fertil Steril 1990 53 (6) 1087-1090
14. Awonuga A O., Pittrof R J., Zaidi J, Dean N, Jacobs H S., Tan S L. Elective cryopreservation of all embryos in women at risk of developing ovarian hyperstimulation syndrome may not prevent the condition but reduces the live birth rate. J Assist Reprod Genet 1996 13 (5) 401-406 (Pubitemid 26161572)
15. Fitzmaurice G J., Boylan C, McClure N. Are pregnancy rates compromised following embryo freezing to prevent OHSS? Ulster Med J 2008 77 (3) 164-167
16. D'Angelo A, Amso N N. Embryo freezing for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 2007 (3) CD002806
17. Shaker A G., Zosmer A, Dean N, Bekir J S., Jacobs H S., Tan S L. Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil Steril 1996 65 (5) 992-996
18. Ferraretti A P., Gianaroli L, Magli C, Fortini D, Selman H A., Feliciani E. Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety. Hum Reprod 1999 14 (6) 1457-1460
19. Aboulghar M, Evers J H., Al-Inany H. Intra-venous albumin for preventing severe ovarian hyperstimulation syndrome. Cochrane Database Syst Rev 1999 (4)
20. Granne I, Child T, Hartshorne G British Fertility Society. Embryo cryopreservation: evidence for practice. Hum Fertil (Camb) 2008 11 (3) 159-172
21. Eftekhari-Yazdi P, Valojerdi M R., Ashtiani S K., Eslaminejad M B., Karimian L. Effect of fragment removal on blastocyst formation and quality of human embryos. Reprod Biomed Online 2006 13 (6) 823-832
22. Lewis S E., West M C., Fleming R. Sperm and embryo cryopreservation practice in licensed clinics in the UK endorsed by The British Fertility Society. Hum Fertil (Camb) 2006 9 (1) 15-26
23. Menezo Y. Cryopreservation of IVF embryos: which stage? Eur J Obstet Gynecol Reprod Biol 2004 113 (Suppl 1) S28-S32
24. Hoover L, Baker A, Check J H., Lurie D, Summers D. Clinical outcome of cryopreserved human pronuclear stage embryos resulting from intracytoplasmic sperm injection. Fertil Steril 1997 67 (4) 621-624
25. Oatway C, Gunby J, Daya S. Day three versus day two embryo transfer following in vitro fertilization or intracytoplasmic sperm injection. Cochrane Database Syst Rev 2004 (2) CD004378
26. Gardner D K. Development of serum-free media for the culture and transfer of human blastocysts. Hum Reprod 1998 13 (Suppl 4) 218-225
27. Hartshorne G M., Elder K, Crow J, Dyson H, Edwards R G. The influence of in-vitro development upon post-thaw survival and implantation of cryopreserved human blastocysts. Hum Reprod 1991 6 (1) 136-141
28. Veeck L L., Bodine R, Clarke R N. et al. High pregnancy rates can be achieved after freezing and thawing human blastocysts. Fertil Steril 2004 82 (5) 1418-1427
29. Fuller B, Paynter S. Fundamentals of cryobiology in reproductive medicine. Reprod Biomed Online 2004 9 (6) 680-691
30. Blake D, Proctor M, Johnson N, Olive D. Cleavage stage versus blastocyst stage embryo transfer in assisted conception. Cochrane Database Syst Rev 2005 (4) CD002118
31. Selman H, Brusco G F., Fiorini F, Barnocchi N, Mariani M, El-Danasouri I. Vitrification is a highly efficient method to cryopreserve human embryos in in vitro fertilization patients at high risk of developing ovarian hyperstimulation syndrome. Fertil Steril 2009 91 (4, Suppl) 1611-1613
32. Wennerholm U B., Hamberger L, Nilsson L, Wennergren M, Wikland M, Bergh C. Obstetric and perinatal outcome of children conceived from cryopreserved embryos. Hum Reprod 1997 12 (8) 1819-1825
33. Al-Inany H G., Abu-Seta A M., Aboulgher M. Gonadotrpophin-releasing hromone antoagonists for assisted conception. Cochran Database of Systematic Review 2006 issue 3